Placental Enzymes and Transporters: New Functions and Genetic Polymorphisms - A Workshop Report

Placenta

Volumn 28, Issue SUPPL., 2007, Pages

  Shiverick, K ^a   Ino, K ^b   Harada, T ^c   Keelan, J ^d   Kikkawa, F ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Drug metabolism polymorphisms; Placental ABC transporters; Placental aminopeptidases; Placental arginase; Thrombophilias in pregnancy

Indexed keywords

ABC TRANSPORTER; ACYLSPHINGOSINE DEACYLASE; ANGIOTENSIN II; ARGINASE; ARGININE; AROMATIC HYDROCARBON RECEPTOR; BLOOD CLOTTING FACTOR 5 LEIDEN; BREAST CANCER RESISTANCE PROTEIN; CYTOCHROME P450 1A1; ENDOTHELIN 1; GLUTAMYL AMINOPEPTIDASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; GONADORELIN; LOW MOLECULAR WEIGHT HEPARIN; MEMBRANE METALLOENDOPEPTIDASE; MULTIDRUG RESISTANCE PROTEIN 1; PEPTIDASE; PLACENTA ENZYME; PROTEIN C; PROTEIN S; PROTHROMBIN; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; ASTHMA; ATOPY; BIRTH WEIGHT; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CYTOTROPHOBLAST; DRUG METABOLISM; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; ENZYME ACTIVITY; GENETIC POLYMORPHISM; HUMAN; MATERNAL SMOKING; PLACENTA DEVELOPMENT; PLACENTA VILLUS; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN DEGRADATION; PROTEIN S DEFICIENCY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYNCYTIOTROPHOBLAST; THROMBOPHILIA; TROPHOBLAST;

ANIMALS; ARGINASE; ATP-BINDING CASSETTE TRANSPORTERS; FEMALE; GLUTAMYL AMINOPEPTIDASE; HUMANS; HYDROLASES; NEPRILYSIN; PEPTIDE HYDROLASES; PHARMACEUTICAL PREPARATIONS; PLACENTA; POLYMORPHISM, GENETIC; PREGNANCY; THROMBOPHILIA;

EID: 33947715814     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2007.01.019     Document Type: Article

References (27)

1. Shipp M.A., and Look A.T. Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key. Blood 82 (1993) 1052-1070
2. Ino K., Uehara C., Kikkawa F., Kajiyama H., Shibata K., Suzuki T., et al. Enhancement of aminopeptidase A expression during angiotensin II-induced choriocarcinoma cell proliferation through AT1 receptor involving protein kinase C- and mitogen-activated protein kinase-dependent signaling pathway. J Clin Endocrinol Metab 88 (2003) 3973-3982
3. Uehara C., Ino K., Suzuki T., Kajiyama H., Kikkawa F., Nagasaka T., et al. Upregulation of neutral endopeptidase expression and enzymatic activity during the differentiation of human choriocarcinoma cells. Placenta 22 (2001) 540-549
4. Helisalmi S., Hiltunen M., Vepsalainen S., Iivonen S., Mannermaa A., Lehtovirta M., et al. Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients. J Neurol Neurosurg Psychiatry 75 (2004) 1746-1748
5. Yamamoto N., Nakayama J., Yamakawa-Kobayashi K., Hamaguchi H., Miyazaki R., and Arinami T. Identification of 33 polymorphisms in the adipocyte-derived leucine aminopeptidase (ALAP) gene and possible association with hypertension. Hum Mutat 19 (2002) 251-257
6. Wu G., and Morris Jr. S.M. Arginine metabolism: nitric oxide and beyond. Biochem J 336 (1998) 1-17
7. Boucher J.L., Moali C., and Tenu J.P. Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for l-arginine utilization. Cell Mol Life Sci 55 (1999) 1015-1028
8. Ishikawa T., Harada T., Koi H., Kubota T., Azuma H., and Aso T. Identification of arginase in human placental villi. Placenta 28 (2006) 133-138
9. Ganapathy V., Prasad P.D., Ganapathy M.E., and Leibach F.H. Placental transporters relevant to drug distribution across the maternal-fetal interface. J Pharmacol Exp Ther 294 (1996) 413-420
10. Eveseenko E., Paxton Jw, and Keelan Ja. Active transport across the human placenta: impact on drug efficacy and toxicity. Expert Opin Drug Metabol Toxicol 2 (2006) 51-69
11. Jonker J.W., Smit J.W., Brinkhuis R.F., Maliepaard M., Beijnen J.H., Schellens J.H., et al. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J Natl Cancer Inst 92 (2000) 1651-1656
12. Borst P., Zelcer N., and Van Helvoort A. ABC transporters in lipid transport. Biochim Biophys Acta 1486 (2000) 128-144
13. Pettus B.J., Chalfant C.E., and Hannun Y.A. Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta 1585 (2002) 114-125
14. Hitzl M., Schaeffeler E., Hocher B., Slowinski T., Halle H., Eichelbaum M., et al. Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1). Pharmacogenetics 14 (2004) 309-318
15. Tanabe M., Ieiri I., Nagata N., Inoue K., Ito S., Kanamori Y., et al. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther 297 (2001) 1137-1143
16. Kobayashi D., Ieiri I., Hirota T., Takane H., Maegawa S., Kigawa J., et al. Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta. Drug Metab Dispos 33 (2005) 94-101
17. Turner J.G., Gump J.L., Zhang C., Cook J.M., Marchion D., Hazlehurst L., et al. ABCG2 expression, function and promoter methylation in human multiple myeloma. Blood 108 (2006) 3881-3889
18. Sasaki S., Kondo T., Sata F., Saijo Y., Katoh S., Nakajima S., et al. Maternal smoking during pregnancy and genetic polymorphisms in the Ah receptor, CYP1A1 and GSTM1 affect infant birth size in Japanese subjects. Mol Hum Reprod 12 (2006) 77-83
19. Saijo Y., Sata F., Yamada H., Suzuki K., Sasaki S., Kondo T., et al. Ah receptor, CYP1A1, CYP1A2 and CYP1B1 gene polymorphisms are not involved in the risk of recurrent pregnancy loss. Mol Hum Reprod 10 (2004) 729-733
20. Raijmakers M.T., de Galan-Roosen T.E., Schilders G.W., Merkus J.M., Steegers E.A., and Peters W.H. The Tyr113His polymorphism in exon 3 of the microsomal epoxide hydrolase gene is a risk factor for perinatal mortality. Acta Obstet Gynecol Scand 83 (2004) 1056-1060
21. Zusterzeel P.L., Nelen W.L., Roelofs H.M., Peters W.H., Blom H.J., and Steegers E.A. Polymorphisms in biotransformation enzymes and the risk for recurrent early pregnancy loss. Mol Hum Reprod 6 (2000) 474-478
22. Wang X., Zuckerman B., Pearson C., Kaufman G., Chen C., Wang G., et al. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 287 (2002) 195-202
23. Sood R., Kalloway S., Mast A.E., Hillard C.J., and Weiler H. Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells. Blood 107 8 (Apr 15 2006) 3173-3180
24. Lissalde-Lavigne G., Cochery-Nouvellon E., Mercier E., Quere I., Dauzat M., Mares P., et al. The association between hereditary thrombophilias and pregnancy loss. Haematologica 90 (2005) 1223-1230
25. Robertson L., Wu O., Langhorne P., Twaddle S., Clark P., Lowe G.D., et al. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. Br J Haematol 132 (2006) 171-196
26. Gris J.C., Lissalde-Lavigne G., Quere I., Dauzat M., and Mares P. Prophylaxis and treatment of thrombophilia in pregnancy. Curr Opin Hematol 13 (2006) 376-381
27. Gibson C.S., MacLennan A.H., Janssen N.G., Kist W.J., Hague W.M., Haan E.A., et al. Associations between fetal inherited thrombophilia and adverse pregnancy outcomes. Am J Obstet Gynecol 194 (2006) 947 e1-10